Sana Biotechnology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -3,895 | -3,746 | -7,541 |
EBITDA | -46,396 | -103,729 | -80,576 |
EBIT | -50,291 | -107,475 | -88,117 |
Net Income | -50,291 | -107,475 | -88,117 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -71,597 | -81,477 | -66,005 |
Cash | 138,790 | 180,886 | 137,349 |
Basic Shares | 234,440 | 217,290 | 197,317 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -30,865 | -27,731 | -17,914 | -10,171 |
EBITDA | -252,390 | -256,939 | -345,839 | -280,228 |
EBIT | -276,947 | -272,564 | -356,909 | -286,149 |
Net Income | -283,255 | -266,388 | -344,182 | -278,637 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -74,575 | 134,899 | ||
Free Cash Flow | -273,614 | -310,926 | -280,916 | -161,854 |
Cash | 133,517 | 176,765 | 253,029 | 411,995 |
Basic Shares | 194,541 | 188,344 | 166,433 | 187,505 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$0.32 |
2024-03-31 | -$0.32 |
2023-12-31 | -$0.41 |
